XML 60 R50.htm IDEA: XBRL DOCUMENT v3.20.2
Share-Based Compensation and Capital Stock - Summary of Change in Stock-Based Award Activity (Details)
6 Months Ended
Jun. 30, 2020
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding, ending balance (in shares) 1,000,000.0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Performance-based leveraging - weighted average grant date fair value (in dollars per share) | $ / shares $ 61.31
Stock options  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding, beginning balance (in shares) 873,895
Granted (in shares) 158,620
Exercised/vested (in shares) (52,010)
Expired (in shares) 0
Forfeited (in shares) (3,696)
Outstanding, ending balance (in shares) 976,809
Options exercisable, ending balance (in shares) 634,948
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Beginning balance - weighted average exercise price (in dollars per share) | $ / shares $ 61.69
Granted - weighted average exercise price (in dollars per share) | $ / shares 91.28
Exercised/vested - weighted average exercise price (in dollars per share) | $ / shares 53.21
Expired - weighted average exercise price (in dollars per share) | $ / shares 0
Forfeited - weighted average exercise price (in dollars per share) | $ / shares 91.28
Ending balance - weighted average exercise price (in dollars per share) | $ / shares 66.84
Options exercisable, ending balance - weighted average exercise price (in dollars per share) | $ / shares $ 57.51
Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Roll Forward]  
Weighted average remaining contractual term - outstanding, ending balance 2 years 6 months
Weighted average remaining contractual term - options exercisable, ending balance 2 years 6 months
Restricted stock  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Outstanding, beginning balance (in shares) 312,097
Granted (in shares) 131,268
Exercised/vested (in shares) (114,549)
Forfeited (in shares) (34,926)
Outstanding, ending balance (in shares) 293,890
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Beginning balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 75.23
Granted - weighted average grant date fair value (in dollars per share) | $ / shares 88.59
Exercised/vested - weighted average grant date fair value (in dollars per share) | $ / shares 69.48
Forfeited - weighted average grant date fair value (in dollars per share) | $ / shares 81.94
Ending balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 82.64
Performance Vested Restricted Stock Units  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Outstanding, beginning balance (in shares) 330,716
Granted (in shares) 93,388
Performance-based leveraging (in shares) 30,116
Exercised/vested (in shares) (176,471)
Expired (in shares) (16,117)
Forfeited (in shares) (16,039)
Outstanding, ending balance (in shares) 245,593
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Beginning balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 70.03
Granted - weighted average grant date fair value (in dollars per share) | $ / shares 91.28
Exercised/vested - weighted average grant date fair value (in dollars per share) | $ / shares 58.68
Expired - weighted average grant date fair value (in dollars per share) | $ / shares 60.50
Forfeited - weighted average grant date fair value (in dollars per share) | $ / shares 82.23
Ending balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 85.03